SlideShare uma empresa Scribd logo
1 de 19
Baixar para ler offline
Alzheimer’s Disease
Presented to : Sir. Asif Shahzad
Presented by : Mahnoor Shahzad
Lyallpur institute of management & sciences
Department of biochemistry
Contents
 Introduction to Alzheimer’s disease
 Origin of Alzheimer’s disease
 Meaning
 Incidence
 Etiology
 Mechanism of action
 Risk factors
 Symptoms
 Prevention
 Treatment
 Drugs against Alzheimer’s disease
Introduction to Alzheimer’s disease:
 Alzheimer’s disease is a degenerative
brain disorder of unknown etiology
which is most common form of
dementia, that usually starts in late
middle age or in old age, results in
progressivememory loss, impaired
thinking, disorientation and changes
in personality and mood. There is a
degeneration in the brain neurons
especially in the cerebral cortex and
presence of neurofibrillarytangles
and plaques containing beta-amyloid
cells.
Origin of Alzheimer’s disease:
 The disease was first described by Dr. Alois Alzheimer,
a German physician, in 1906
 Alzheimer had a patient named Auguste D in her
fifties who suffered from what seems to be a mental
illness. But when she died in 1906, an autopsy
revealed dense deposits, now called neuritic plaques
outside and around the nerve cells in her brain. Inside
the cells were twisted strands of fibre, or neurofibrillary
tangles. Since Dr. Alois Alzheimer was the first person
who discovered the disease, AD was named after it.
Meaning:
 Alzheimer’s disease is a chronic, irreversible
disease that affects the cells of the brain
and cause progressive impairment of
memory and cognition functioning.
 Alzheimer’s disease is a brain disorder
which gradually destroys the ability to
reason, remember, imagine and learn.
Incidence:
 About 3 percent of men and women ages 65-
74 have AD, and nearly half of those age 85
and older may have the disease.
 About 3,60,000 new cases of Alzheimer’s
disease are diagnosed each year.
Etiology:
 The exact causes of Alzheimer’s diseasearen’t fullyunderstood. But at a basic
level, brain proteins fail to function normally,whichdisrupts the work of brain
cells (neurons)and triggers a series of toxic events. Neurons are damaged, lose
connections to each other and eventually die.
 Researchers trying to understandthe cause of Alzheimer’s disease are focused
on the role of two proteins:
 Plaques:
Beta-amyloidis a fragment of a larger protein.When these fragments
cluster together, they appear to have a toxic effect on neurons and to disrupt
cell-to-cell communication. These clusters form larger deposits called amyloid
plaques or Senile plaques. Beta-amyloidprotein is formedfrom the breakdown of
a larger protein,called amyloid precursor protein (APP).
 Role of Chaperone Enzyme
 Pin I: Recently an enzyme Pin I has been found which is necessary for
formation of normal Tau protein. Absence of Pin I in this condition produces
the abnormal Tau protein.
 Tangles: Tau proteins play a part in a neuron’s internal support and
transport system to carry nutrients and other essential materials. In
Alzheimer’s disease, tau proteins change shape and organize themselves
into structures called neurofibrillarytangles. The tangles disrupt the
transport system and are toxic to cells. The synthesis of acetylcholine is
reduced leading to memory loss which affects the cholinergic neurons.
Mechanism of action:
Risk factors:
 Age:
 Increasing age is the greatest known risk factor for Alzheimer’s disease.Alzheimer’s is
not a part of normal aging, but as you grow older the likelihoodof developing
Alzheimer’s diseaseincreases.
 Family history and genetic:
 Your risk of developingAlzheimer’s is somewhat higher if a first-degreerelative—
your parent or sibling — has the disease. Most geneticmechanisms of Alzheimer’s
among families remain largely unexplained, and the geneticfactors are likely
complex.
 One better understoodgeneticfactor is a form of the apolipoproteinE gene (APOE).
A variation of the gene, APOE e4, increases the risk of Alzheimer’s disease.
 Down syndrome:
 Many people with Down syndrome develop Alzheimer’s disease. This is
likelyrelated to having three copies of chromosome 21 — and
subsequently three copies of the gene for the protein that leads to the
creation of beta-amyloid.
 Head trauma:
 People who’ve had a severe head trauma have a greater risk of
Alzheimer’s disease.
 Several large studies found that in people age 50 years or older who had a
traumatic brain injury (TBI), the risk of dementia and Alzheimer’sdisease
increased. The risk increases in people with more-
 Air pollution:
 Studies in animals have indicated that air pollution particulates can speed
degeneration of the nervous system. And human studies have found that air
pollution exposure — particularlyfrom traffic exhaust and burning wood — is
associated with greater dementia risk.
 Excessive alcohol consumption:
 Drinking large amounts of alcohol has long been known to cause brain changes.
Several large studies and reviews found that alcohol use disorders were linked to
an increased risk of dementia.
 Poor sleep patterns:
 Research has shown that poor sleep patterns, such as difficulty falling asleep or
staying asleep, are associated with an increased risk of Alzheimer’sdisease.
 Lifestyle and heart health:
 Research has shown that the same risk factors associated with heart
disease may also increase the risk of Alzheimer’s disease. These include:
 Lack of exercise
 Obesity
 Smoking
 High blood pressure
 High cholesterol
 Poorly controlled type 2 diabetes
Symptoms:
 People with Alzheimer’s may:
1. Loss of memory with inability to recall.
2. Difficulty in performing similar tasks.
3. Forget time, place, way and purpose.
4. Poor judgement.
5. Misplacing objects e.g wallet, key, mobile etc
6. Depression, anxiety and insomnia.
7. Have trouble finding the right words to identify objects, express
thoughts or take part in conversations.
8. Eventually forget the names of family members and everyday
objects.
9. Repeat statements and questions over and over
Prevention:
 Alzheimer’s disease is not a preventable condition. However, a number of lifestyle risk
factors for Alzheimer’s can be modified. Evidence suggests that changes in diet, exercise
and habits — steps to reduce the risk of cardiovascular disease — may also lower your risk
of developing Alzheimer’s disease and other disorders that cause dementia. Heart-
healthy lifestyle choices that may reduce the risk of Alzheimer’s include the following:
1. Prevent and manage high blood pressure.
2. Manage blood sugar.
3. Maintain a healthy weight.
4. Be physically active.
5. Quit smoking.
6. Exercising regularly.
7. Get enough sleep
Treatment:
 Alzheimer’s Disease can be treated either
by
1. Increasing the level of Acetylcholine
2. Inhibiting the destruction of Acetylcholine
by decreasing concentration of Acetyl
cholinesterase.
Drugs against Alzheimer’s disease:
 Cholinesterase inhibitors:
Tacrine, was a first drug approved to treat Alzheimer’s disease but this drug is
not used yet because it causes hepatotoxicity and as well as nausea,
vomiting and abdominal cramps.
Rivastigmine, is a newer drug with minimum side effects.
 Nootropic Agent:
Drugs used to specifically facilitate learning or memory. These drugs stimulate
happiness.
For example, Piracetam.
 Galantamine
Thank you!
Any questions?

Mais conteúdo relacionado

Semelhante a Alzheimer's disease

Alzheimerdisease and apoptosis
Alzheimerdisease and apoptosisAlzheimerdisease and apoptosis
Alzheimerdisease and apoptosis
eman youssif
 
Kiki's project
Kiki's projectKiki's project
Kiki's project
r.yarza
 
Alzheimers presentation.docx
Alzheimers presentation.docxAlzheimers presentation.docx
Alzheimers presentation.docx
teredeloscobos
 
Degenerative diseases in aging patients
Degenerative diseases in aging patientsDegenerative diseases in aging patients
Degenerative diseases in aging patients
Gustavo Duarte Viana
 
ALZHEMERS HEALTH EQUITY final Copy-1.pptx
ALZHEMERS HEALTH EQUITY  final  Copy-1.pptxALZHEMERS HEALTH EQUITY  final  Copy-1.pptx
ALZHEMERS HEALTH EQUITY final Copy-1.pptx
DrPreetiThakurChouha
 

Semelhante a Alzheimer's disease (20)

Alzheimer’s disease
Alzheimer’s diseaseAlzheimer’s disease
Alzheimer’s disease
 
Alzheimer
AlzheimerAlzheimer
Alzheimer
 
Alzheimer Disease and Mind Function
Alzheimer Disease and Mind FunctionAlzheimer Disease and Mind Function
Alzheimer Disease and Mind Function
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Alzheimers Causes and Treatments
Alzheimers Causes and TreatmentsAlzheimers Causes and Treatments
Alzheimers Causes and Treatments
 
Alzheimerdisease and apoptosis
Alzheimerdisease and apoptosisAlzheimerdisease and apoptosis
Alzheimerdisease and apoptosis
 
Kiki's project
Kiki's projectKiki's project
Kiki's project
 
Alzheimer's disease
Alzheimer's diseaseAlzheimer's disease
Alzheimer's disease
 
Alzheimer's disease
Alzheimer's disease Alzheimer's disease
Alzheimer's disease
 
Kiki's project
Kiki's projectKiki's project
Kiki's project
 
Alzheimers presentation.docx
Alzheimers presentation.docxAlzheimers presentation.docx
Alzheimers presentation.docx
 
Alzheimers presentation.docx
Alzheimers presentation.docxAlzheimers presentation.docx
Alzheimers presentation.docx
 
Neurodegenerative diseases ppt
Neurodegenerative diseases ppt Neurodegenerative diseases ppt
Neurodegenerative diseases ppt
 
Alzheimer’s disease full
Alzheimer’s disease   fullAlzheimer’s disease   full
Alzheimer’s disease full
 
Cate buline are buburuza
Cate buline are buburuzaCate buline are buburuza
Cate buline are buburuza
 
Alzheimers disease by Ritika soni
Alzheimers disease by Ritika soniAlzheimers disease by Ritika soni
Alzheimers disease by Ritika soni
 
Alzheimers Diseases
Alzheimers DiseasesAlzheimers Diseases
Alzheimers Diseases
 
Degenerative diseases in aging patients
Degenerative diseases in aging patientsDegenerative diseases in aging patients
Degenerative diseases in aging patients
 
Causes Of Dementia
Causes Of DementiaCauses Of Dementia
Causes Of Dementia
 
ALZHEMERS HEALTH EQUITY final Copy-1.pptx
ALZHEMERS HEALTH EQUITY  final  Copy-1.pptxALZHEMERS HEALTH EQUITY  final  Copy-1.pptx
ALZHEMERS HEALTH EQUITY final Copy-1.pptx
 

Mais de biocatalysis and Bioremediation lab/GCUF

Eicosanoid.pdf
Eicosanoid.pdfEicosanoid.pdf
genetic counselling.pptx
genetic counselling.pptxgenetic counselling.pptx

Mais de biocatalysis and Bioremediation lab/GCUF (7)

Structural Bioinformatics/Molecular Docking.pptx
Structural Bioinformatics/Molecular Docking.pptxStructural Bioinformatics/Molecular Docking.pptx
Structural Bioinformatics/Molecular Docking.pptx
 
Eicosanoid.pdf
Eicosanoid.pdfEicosanoid.pdf
Eicosanoid.pdf
 
genetic counselling.pptx
genetic counselling.pptxgenetic counselling.pptx
genetic counselling.pptx
 
Mechanism of Enzyme Action..
Mechanism of Enzyme Action..Mechanism of Enzyme Action..
Mechanism of Enzyme Action..
 
Whole genome shotgun sequencing.pptx
Whole genome shotgun sequencing.pptxWhole genome shotgun sequencing.pptx
Whole genome shotgun sequencing.pptx
 
Coronaviruse
CoronaviruseCoronaviruse
Coronaviruse
 
Cancer cell metabolism
Cancer cell metabolismCancer cell metabolism
Cancer cell metabolism
 

Último

Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Sérgio Sacani
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Sérgio Sacani
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSS
LeenakshiTyagi
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Lokesh Kothari
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
RohitNehra6
 
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
PirithiRaju
 

Último (20)

Forensic Biology & Its biological significance.pdf
Forensic Biology & Its biological significance.pdfForensic Biology & Its biological significance.pdf
Forensic Biology & Its biological significance.pdf
 
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
Discovery of an Accretion Streamer and a Slow Wide-angle Outflow around FUOri...
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
TEST BANK For Radiologic Science for Technologists, 12th Edition by Stewart C...
 
DIFFERENCE IN BACK CROSS AND TEST CROSS
DIFFERENCE IN  BACK CROSS AND TEST CROSSDIFFERENCE IN  BACK CROSS AND TEST CROSS
DIFFERENCE IN BACK CROSS AND TEST CROSS
 
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 60009654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
9654467111 Call Girls In Raj Nagar Delhi Short 1500 Night 6000
 
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatidSpermiogenesis or Spermateleosis or metamorphosis of spermatid
Spermiogenesis or Spermateleosis or metamorphosis of spermatid
 
Zoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdfZoology 4th semester series (krishna).pdf
Zoology 4th semester series (krishna).pdf
 
Botany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questionsBotany krishna series 2nd semester Only Mcq type questions
Botany krishna series 2nd semester Only Mcq type questions
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
 
Chemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdfChemistry 4th semester series (krishna).pdf
Chemistry 4th semester series (krishna).pdf
 
fundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomologyfundamental of entomology all in one topics of entomology
fundamental of entomology all in one topics of entomology
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdfPests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
Pests of cotton_Borer_Pests_Binomics_Dr.UPR.pdf
 
Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )Recombination DNA Technology (Nucleic Acid Hybridization )
Recombination DNA Technology (Nucleic Acid Hybridization )
 

Alzheimer's disease

  • 1. Alzheimer’s Disease Presented to : Sir. Asif Shahzad Presented by : Mahnoor Shahzad Lyallpur institute of management & sciences Department of biochemistry
  • 2. Contents  Introduction to Alzheimer’s disease  Origin of Alzheimer’s disease  Meaning  Incidence  Etiology  Mechanism of action  Risk factors  Symptoms  Prevention  Treatment  Drugs against Alzheimer’s disease
  • 3. Introduction to Alzheimer’s disease:  Alzheimer’s disease is a degenerative brain disorder of unknown etiology which is most common form of dementia, that usually starts in late middle age or in old age, results in progressivememory loss, impaired thinking, disorientation and changes in personality and mood. There is a degeneration in the brain neurons especially in the cerebral cortex and presence of neurofibrillarytangles and plaques containing beta-amyloid cells.
  • 4. Origin of Alzheimer’s disease:  The disease was first described by Dr. Alois Alzheimer, a German physician, in 1906  Alzheimer had a patient named Auguste D in her fifties who suffered from what seems to be a mental illness. But when she died in 1906, an autopsy revealed dense deposits, now called neuritic plaques outside and around the nerve cells in her brain. Inside the cells were twisted strands of fibre, or neurofibrillary tangles. Since Dr. Alois Alzheimer was the first person who discovered the disease, AD was named after it.
  • 5. Meaning:  Alzheimer’s disease is a chronic, irreversible disease that affects the cells of the brain and cause progressive impairment of memory and cognition functioning.  Alzheimer’s disease is a brain disorder which gradually destroys the ability to reason, remember, imagine and learn.
  • 6. Incidence:  About 3 percent of men and women ages 65- 74 have AD, and nearly half of those age 85 and older may have the disease.  About 3,60,000 new cases of Alzheimer’s disease are diagnosed each year.
  • 7. Etiology:  The exact causes of Alzheimer’s diseasearen’t fullyunderstood. But at a basic level, brain proteins fail to function normally,whichdisrupts the work of brain cells (neurons)and triggers a series of toxic events. Neurons are damaged, lose connections to each other and eventually die.  Researchers trying to understandthe cause of Alzheimer’s disease are focused on the role of two proteins:  Plaques: Beta-amyloidis a fragment of a larger protein.When these fragments cluster together, they appear to have a toxic effect on neurons and to disrupt cell-to-cell communication. These clusters form larger deposits called amyloid plaques or Senile plaques. Beta-amyloidprotein is formedfrom the breakdown of a larger protein,called amyloid precursor protein (APP).
  • 8.  Role of Chaperone Enzyme  Pin I: Recently an enzyme Pin I has been found which is necessary for formation of normal Tau protein. Absence of Pin I in this condition produces the abnormal Tau protein.  Tangles: Tau proteins play a part in a neuron’s internal support and transport system to carry nutrients and other essential materials. In Alzheimer’s disease, tau proteins change shape and organize themselves into structures called neurofibrillarytangles. The tangles disrupt the transport system and are toxic to cells. The synthesis of acetylcholine is reduced leading to memory loss which affects the cholinergic neurons.
  • 9.
  • 11. Risk factors:  Age:  Increasing age is the greatest known risk factor for Alzheimer’s disease.Alzheimer’s is not a part of normal aging, but as you grow older the likelihoodof developing Alzheimer’s diseaseincreases.  Family history and genetic:  Your risk of developingAlzheimer’s is somewhat higher if a first-degreerelative— your parent or sibling — has the disease. Most geneticmechanisms of Alzheimer’s among families remain largely unexplained, and the geneticfactors are likely complex.  One better understoodgeneticfactor is a form of the apolipoproteinE gene (APOE). A variation of the gene, APOE e4, increases the risk of Alzheimer’s disease.
  • 12.  Down syndrome:  Many people with Down syndrome develop Alzheimer’s disease. This is likelyrelated to having three copies of chromosome 21 — and subsequently three copies of the gene for the protein that leads to the creation of beta-amyloid.  Head trauma:  People who’ve had a severe head trauma have a greater risk of Alzheimer’s disease.  Several large studies found that in people age 50 years or older who had a traumatic brain injury (TBI), the risk of dementia and Alzheimer’sdisease increased. The risk increases in people with more-
  • 13.  Air pollution:  Studies in animals have indicated that air pollution particulates can speed degeneration of the nervous system. And human studies have found that air pollution exposure — particularlyfrom traffic exhaust and burning wood — is associated with greater dementia risk.  Excessive alcohol consumption:  Drinking large amounts of alcohol has long been known to cause brain changes. Several large studies and reviews found that alcohol use disorders were linked to an increased risk of dementia.  Poor sleep patterns:  Research has shown that poor sleep patterns, such as difficulty falling asleep or staying asleep, are associated with an increased risk of Alzheimer’sdisease.
  • 14.  Lifestyle and heart health:  Research has shown that the same risk factors associated with heart disease may also increase the risk of Alzheimer’s disease. These include:  Lack of exercise  Obesity  Smoking  High blood pressure  High cholesterol  Poorly controlled type 2 diabetes
  • 15. Symptoms:  People with Alzheimer’s may: 1. Loss of memory with inability to recall. 2. Difficulty in performing similar tasks. 3. Forget time, place, way and purpose. 4. Poor judgement. 5. Misplacing objects e.g wallet, key, mobile etc 6. Depression, anxiety and insomnia. 7. Have trouble finding the right words to identify objects, express thoughts or take part in conversations. 8. Eventually forget the names of family members and everyday objects. 9. Repeat statements and questions over and over
  • 16. Prevention:  Alzheimer’s disease is not a preventable condition. However, a number of lifestyle risk factors for Alzheimer’s can be modified. Evidence suggests that changes in diet, exercise and habits — steps to reduce the risk of cardiovascular disease — may also lower your risk of developing Alzheimer’s disease and other disorders that cause dementia. Heart- healthy lifestyle choices that may reduce the risk of Alzheimer’s include the following: 1. Prevent and manage high blood pressure. 2. Manage blood sugar. 3. Maintain a healthy weight. 4. Be physically active. 5. Quit smoking. 6. Exercising regularly. 7. Get enough sleep
  • 17. Treatment:  Alzheimer’s Disease can be treated either by 1. Increasing the level of Acetylcholine 2. Inhibiting the destruction of Acetylcholine by decreasing concentration of Acetyl cholinesterase.
  • 18. Drugs against Alzheimer’s disease:  Cholinesterase inhibitors: Tacrine, was a first drug approved to treat Alzheimer’s disease but this drug is not used yet because it causes hepatotoxicity and as well as nausea, vomiting and abdominal cramps. Rivastigmine, is a newer drug with minimum side effects.  Nootropic Agent: Drugs used to specifically facilitate learning or memory. These drugs stimulate happiness. For example, Piracetam.  Galantamine